Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens-Reference-Cited by-同舟云学术

Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens

Published:2017-09 Issue:5 Volume:32 Page:357-366
ISSN:1548-9213
Container-title:Physiology
language:en
Short-container-title:Physiology

Author:

Yanes Cardozo Licy L.¹²³⁴,Romero Damian G.⁵⁴,Reckelhoff Jane F.²⁵⁴

Affiliation:

1. Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi;

2. Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, Mississippi;

3. Women’s Health Research Center, University of Mississippi Medical Center, Jackson, Mississippi; and

4. Cardio Renal Research Center, University of Mississippi Medical Center, Jackson, Mississippi

5. Department of Biochemistry, University of Mississippi Medical Center, Jackson, Mississippi;

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder that affects reproductive-age women. Hyperandrogenemia is present in a significant fraction (~80%) of women with PCOS. Increased prevalence of cardiometabolic risk factors is frequently observed in PCOS women. The present review aims to highlight the key role of androgens in mediating the negative cardiometabolic profile observed in PCOS women.

Funder

American Heart Association (AHA)

Endocrine Fellows Foundation

HHS | National Institutes of Health (NIH)

Publisher

American Physiological Society

Subject

Physiology

Link

https://www.physiology.org/doi/pdf/10.1152/physiol.00030.2016

Reference126 articles.

1. Plasma nesfatin-1 levels are increased in patients with polycystic ovary syndrome